Clinical relevance This study compares a novel photoscreening device with a previously validated one in a school-age population. It highlights a tendency of the new device to underestimate myopic spherical equivalent and overestimate hyperopic cases. Purpose To compare the PlusoptiX A16 and Vision Screener V100 photoscreeners in a study population of school-age children. Methods One hundred and thirty-three children, with a mean age of 6.4 ± 0.5 years, were evaluated using both the PlusoptiX A16 and Vision Screener V100 photoscreeners. The measurements were taken in random order in a room with diminished ambient lighting. Results The mean refractive error values for the M component were 0.27 ± 0.67D (PlusoptiX A16) and 0.21 ± 0.58D (Vision Screener V100). For the J0 component, means were 0.16 ± 0.38D (PlusoptiX A16) and 0.06 ± 0.33D (Vision Screener V100) and for theJ45 component the means were 0.03 ± 0.17D (PlusoptiX A16) and 0.06 ± 0.22D (Vision Screener V100). When compared both instruments, statistically significant differences were observed for the M (p=0.017) and J0 (p=0.004) components. The agreement rates between PlusoptiX A16 and Vision Screener V100 across different refractive components were 80.5% for sphere, 82.0% for cylinder, and 40.6% for axis when considering a range of ±0.75 D for sphere and cylinder and ±25.0 degrees for cylinder axis. Simultaneously considering all three conditions, the overall agreement was 73.7%. Conclusion The Vision Screener V100, while generally aligning well with PlusoptiX A16, tends to underestimate myopic spherical equivalent, overestimate hyperopic cases, and underestimate J0 astigmatism.
No takes yet. Share an insight, caveat, or question.
Jorge et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: